Paolo Cascio

3.2k total citations
45 papers, 2.5k citations indexed

About

Paolo Cascio is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Paolo Cascio has authored 45 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Immunology. Recurrent topics in Paolo Cascio's work include Ubiquitin and proteasome pathways (30 papers), Peptidase Inhibition and Analysis (12 papers) and Endoplasmic Reticulum Stress and Disease (11 papers). Paolo Cascio is often cited by papers focused on Ubiquitin and proteasome pathways (30 papers), Peptidase Inhibition and Analysis (12 papers) and Endoplasmic Reticulum Stress and Disease (11 papers). Paolo Cascio collaborates with scholars based in Italy, United States and France. Paolo Cascio's co-authors include Alfred L. Goldberg, Kenneth L. Rock, Fulvia Cerruti, Tomo Šarić, Alwin Köhler, Kee Min Woo, David Leggett, Daniel Finley, Simone Cenci and Laura Oliva and has published in prestigious journals such as The EMBO Journal, Blood and Molecular Cell.

In The Last Decade

Paolo Cascio

43 papers receiving 2.5k citations

Peers

Paolo Cascio

ONCOL

IMMUN

EPIDE

Seth Sadis United States

Günther R. Adolf Austria

Karsten Sauer United States

Olivier Brison France

Nicolas Reymond France

Eric S. Martin United States

Christian Hagemeier Germany

Cynthia J. Guidos Canada

André Nussenzweig United States

Elsa Callén United States

Seth Sadis United States

Paolo Cascio

2.0k ×1.0

752 ×1.1

ONCOL

363 ×0.6

IMMUN

723 ×1.3

666 ×1.4

EPIDE

Citations per year, relative to Paolo Cascio Paolo Cascio (= 1×) peers Seth Sadis

Countries citing papers authored by Paolo Cascio

Since Specialization

Citations

This map shows the geographic impact of Paolo Cascio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Cascio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Cascio more than expected).

Fields of papers citing papers by Paolo Cascio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Cascio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Cascio. The network helps show where Paolo Cascio may publish in the future.

Co-authorship network of co-authors of Paolo Cascio

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Cascio. A scholar is included among the top collaborators of Paolo Cascio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Cascio. Paolo Cascio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olivari, Davide, Fulvia Cerruti, Paolo Cascio, et al.. (2025). Multiple organs exhibit exacerbated cachexia in male mice with colon cancer than females. Journal of Advanced Research.

Cascio, Paolo. (2024). PA28γ, the ring that makes tumors invisible to the immune system?. Biochimie. 226. 136–147.

Tundo, Grazia Raffaella, Diego Sbardella, Francesco Oddone, et al.. (2022). Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug. Biomolecules. 12(2). 315–315. 2 indexed citations

Tundo, Grazia Raffaella, Paolo Cascio, Danilo Milardi, et al.. (2022). Targeting immunoproteasome in neurodegeneration: A glance to the future. Pharmacology & Therapeutics. 241. 108329–108329. 8 indexed citations

Cerruti, Fulvia, Angela Cattaneo, Angela Bachi, et al.. (2021). PA28γ–20S proteasome is a proteolytic complex committed to degrade unfolded proteins. Cellular and Molecular Life Sciences. 79(1). 45–45. 12 indexed citations

Oliva, Laura, Ugo Orfanelli, Massimo Resnati, et al.. (2017). The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity. Blood. 129(15). 2132–2142. 60 indexed citations

Cerruti, Fulvia, Chiara Salio, Laura Oliva, et al.. (2017). Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis. Scientific Reports. 7(1). 17626–17626. 8 indexed citations

Cerruti, Fulvia, Nadia Benaroudj, Angela Bachi, et al.. (2014). PA28αβ Reduces Size and Increases Hydrophilicity of 20S Immunoproteasome Peptide Products. Chemistry & Biology. 21(4). 470–480. 51 indexed citations

Cerruti, Fulvia, et al.. (2014). Enhanced rate of degradation of basic proteins by 26S immunoproteasomes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(9). 1942–1947. 29 indexed citations

10.

Cascio, Paolo, et al.. (2012). MHC Class I-Related Antigen-Processing Machinery Component Defects in Feline Mammary Carcinoma. Translational Oncology. 5(1). 48–55. 6 indexed citations

11.

Cerruti, Fulvia, Marina Martano, Emanuela Morello, Paolo Buracco, & Paolo Cascio. (2010). Proteasomes are not a Target for Doxorubicin in Feline Injection-Site Sarcoma. Journal of Comparative Pathology. 143(2-3). 164–172. 1 indexed citations

12.

Cascio, Paolo, Laura Oliva, Fulvia Cerruti, et al.. (2008). Dampening Ab responses using proteasome inhibitors following in vivo B cell activation. European Journal of Immunology. 38(3). 658–667. 51 indexed citations

13.

Cerruti, Fulvia, Marina Martano, Claudio Petterino, et al.. (2007). Enhanced Expression of Interferon-γ-Induced Antigen-Processing Machinery Components in a Spontaneously Occurring Cancer. Neoplasia. 9(11). 960–969. 23 indexed citations

14.

Petterino, Claudio, Marina Martano, Paolo Cascio, et al.. (2006). Immunohistochemical Study of STAT3 Expression in Feline Injection-site Fibrosarcomas. Journal of Comparative Pathology. 134(1). 91–100. 7 indexed citations

15.

Cenci, Simone, Alexandre Mezghrani, Paolo Cascio, et al.. (2006). Progressively impaired proteasomal capacity during terminal plasma cell differentiation. The EMBO Journal. 25(5). 1104–1113. 130 indexed citations

16.

Martano, Marina, Emanuela Morello, Selina Iussich, et al.. (2004). Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases. The Veterinary Journal. 170(1). 84–90. 50 indexed citations

17.

Goldberg, Alfred L., Paolo Cascio, Tomo Šarić, & Kenneth L. Rock. (2002). The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Molecular Immunology. 39(3-4). 147–164. 258 indexed citations

18.

Cascio, Paolo. (2002). Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. The EMBO Journal. 21(11). 2636–2645. 168 indexed citations

19.

Benaroudj, Nadia, Edit Tarcsa, Paolo Cascio, & Alfred L. Goldberg. (2001). The unfolding of substrates and ubiquitin-independentprotein degradation by proteasomes. Biochimie. 83(3-4). 311–318. 68 indexed citations

20.

Mo, Xiaofen, et al.. (1999). Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides. The Journal of Immunology. 163(11). 5851–5859. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact